FDA Inspection 1164289 — Carter BloodCare - HEB
The FDA completed an inspection of Carter BloodCare - HEB on Mar 7, 2022 in Bedford, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 7, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Bedford, TX (United States)